BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carrarini C, Russo M, Dono F, Di Pietro M, Rispoli MG, Di Stefano V, Ferri L, Barbone F, Vitale M, Thomas A, Sensi SL, Onofrj M, Bonanni L. A Stage-Based Approach to Therapy in Parkinson's Disease. Biomolecules 2019;9:E388. [PMID: 31434341 DOI: 10.3390/biom9080388] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Gubinelli F, Cazzolla G, Negrini M, Kulacz I, Mehrdadian A, Tomasello G, Venuti C, Sarauskyte L, Jacobs F, Manfredsson F, Davidsson M, Heuer A. Lateralized deficits after unilateral AAV-vector based overexpression of alpha-synuclein in the midbrain of rats on drug-free behavioural tests. Behavioural Brain Research 2022. [DOI: 10.1016/j.bbr.2022.113887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Oh E, Park J, Youn J, Jang W. Anodal Transcranial Direct Current Stimulation Could Modulate Cortical Excitability and the Central Cholinergic System in Akinetic Rigid-Type Parkinson's Disease: Pilot Study. Front Neurol 2022;13:830976. [DOI: 10.3389/fneur.2022.830976] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Heise N, Friedrich S, Temml V, Schuster D, Siewert B, Csuk R. N-methylated diazabicyclo[3.2.2]nonane substituted triterpenoic acids are excellent, hyperbolic and selective inhibitors for butyrylcholinesterase. Eur J Med Chem 2022;227:113947. [PMID: 34731766 DOI: 10.1016/j.ejmech.2021.113947] [Reference Citation Analysis]
4 Di Stefano A, Marinelli L. Advances in Parkinson's Disease Drugs. Biomolecules 2021;11:1640. [PMID: 34827638 DOI: 10.3390/biom11111640] [Reference Citation Analysis]
5 Liu Y, Sigman JA, Bruce LA, Wolfson AJ. Thimet Oligopeptidase—A Classical Enzyme with New Function and New Form. Immuno 2021;1:332-46. [DOI: 10.3390/immuno1040022] [Reference Citation Analysis]
6 Wang JT, Rodrigo AC, Patterson AK, Hawkins K, Aly MMS, Sun J, Al Jamal KT, Smith DK. Enhanced Delivery of Neuroactive Drugs via Nasal Delivery with a Self-Healing Supramolecular Gel. Adv Sci (Weinh) 2021;8:e2101058. [PMID: 34029010 DOI: 10.1002/advs.202101058] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
7 Costa-Ribeiro A, Andrade SMMDS, Férrer MLV, Silva OAPD, Salvador MLS, Smaili S, Lindquist ARR. Can Task Specificity Impact tDCS-Linked to Dual Task Training Gains in Parkinson's Disease? A Protocol for a Randomized Controlled Trial. Front Aging Neurosci 2021;13:684689. [PMID: 34276344 DOI: 10.3389/fnagi.2021.684689] [Reference Citation Analysis]
8 Si W, Huang Z, Li X, Zhao L, Ji Y, Li H, Liu X, Ye S, Chen D, Liu H, Kuang W, Zhu M. Super-enhancer-driven Sorting Nexin 5 expression promotes dopaminergic neuronal ferroptosis in Parkinson's disease models. Biochem Biophys Res Commun 2021;567:35-41. [PMID: 34134000 DOI: 10.1016/j.bbrc.2021.06.024] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
9 Ghaderyan P, Fathi G. Inter-limb time-varying singular value: A new gait feature for Parkinson’s disease detection and stage classification. Measurement 2021;177:109249. [DOI: 10.1016/j.measurement.2021.109249] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Li H, Wang H, Zhang L, Wang M, Li Y. Dl-3-n-Butylphthalide Alleviates Behavioral and Cognitive Symptoms Via Modulating Mitochondrial Dynamics in the A53T-α-Synuclein Mouse Model of Parkinson's Disease. Front Neurosci 2021;15:647266. [PMID: 34121985 DOI: 10.3389/fnins.2021.647266] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Magdi A, Sayed Ahmed AM, Elsayed E, Ahmad R, Ramakrishnan S, Gabor MG. Effects of cueing techniques on gait, gait-related mobility, and functional activities in patients with Parkinson’s disease: a systematic review and meta-analysis. Physical Therapy Reviews 2021;26:188-201. [DOI: 10.1080/10833196.2021.1908728] [Reference Citation Analysis]
12 Badwal K, Kiliaki SA, Dugani SB, Pagali SR. Psychosis Management in Lewy Body Dementia: A Comprehensive Clinical Approach. J Geriatr Psychiatry Neurol 2021;:891988720988916. [PMID: 33461372 DOI: 10.1177/0891988720988916] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Rai SN, Singh P, Varshney R, Chaturvedi VK, Vamanu E, Singh MP, Singh BK. Promising drug targets and associated therapeutic interventions in Parkinson's disease. Neural Regen Res 2021;16:1730-9. [PMID: 33510062 DOI: 10.4103/1673-5374.306066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
14 Huang Y, Huang C, Zhang Q, Wu W, Sun J. Serum BDNF discriminates Parkinson's disease patients with depression from without depression and reflect motor severity and gender differences. J Neurol 2021;268:1411-8. [PMID: 33179143 DOI: 10.1007/s00415-020-10299-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
15 Ali AM, Kunugi H. Apitherapy for Parkinson's Disease: A Focus on the Effects of Propolis and Royal Jelly. Oxid Med Cell Longev 2020;2020:1727142. [PMID: 33123309 DOI: 10.1155/2020/1727142] [Cited by in Crossref: 13] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
16 Kurihara K, Nakagawa R, Ishido M, Yoshinaga Y, Watanabe J, Hayashi Y, Mishima T, Fujioka S, Tsuboi Y. Impact of motor and nonmotor symptoms in Parkinson disease for the quality of life: The Japanese Quality-of-Life Survey of Parkinson Disease (JAQPAD) study. J Neurol Sci 2020;419:117172. [PMID: 33065494 DOI: 10.1016/j.jns.2020.117172] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Javed H, Meeran MFN, Azimullah S, Bader Eddin L, Dwivedi VD, Jha NK, Ojha S. α-Bisabolol, a Dietary Bioactive Phytochemical Attenuates Dopaminergic Neurodegeneration through Modulation of Oxidative Stress, Neuroinflammation and Apoptosis in Rotenone-Induced Rat Model of Parkinson's disease. Biomolecules 2020;10:E1421. [PMID: 33049992 DOI: 10.3390/biom10101421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
18 Timpe C, Stegemann S, Barrett A, Mujumdar S. Challenges and opportunities to include patient-centric product design in industrial medicines development to improve therapeutic goals. Br J Clin Pharmacol 2020;86:2020-7. [PMID: 32441052 DOI: 10.1111/bcp.14388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
19 Byeon H. Exploring the Predictors of Rapid Eye Movement Sleep Behavior Disorder for Parkinson's Disease Patients Using Classifier Ensemble. Healthcare (Basel). 2020;8. [PMID: 32369941 DOI: 10.3390/healthcare8020121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
20 Xu F, Na L, Li Y, Chen L. Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci 2020;10:54. [PMID: 32266056 DOI: 10.1186/s13578-020-00416-0] [Cited by in Crossref: 104] [Cited by in F6Publishing: 190] [Article Influence: 52.0] [Reference Citation Analysis]
21 Mendonça IP, Duarte-Silva E, Chaves-Filho AJM, Andrade da Costa BLDS, Peixoto CA. Neurobiological findings underlying depressive behavior in Parkinson's disease: A review. Int Immunopharmacol 2020;83:106434. [PMID: 32224442 DOI: 10.1016/j.intimp.2020.106434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Russo M, Carrarini C, Dono F, Rispoli MG, Di Pietro M, Di Stefano V, Ferri L, Bonanni L, Sensi SL, Onofrj M. The Pharmacology of Visual Hallucinations in Synucleinopathies. Front Pharmacol 2019;10:1379. [PMID: 31920635 DOI: 10.3389/fphar.2019.01379] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
23 Ling L, Jiang Y, Liu Y, Li H, Bari A, Ullah R, Xue J. Role of gold nanoparticle from Cinnamomum verum against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) induced mice model. Journal of Photochemistry and Photobiology B: Biology 2019;201:111657. [DOI: 10.1016/j.jphotobiol.2019.111657] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
24 Krátký M, Štěpánková Š, Houngbedji NH, Vosátka R, Vorčáková K, Vinšová J. 2-Hydroxy-N-phenylbenzamides and Their Esters Inhibit Acetylcholinesterase and Butyrylcholinesterase. Biomolecules 2019;9:E698. [PMID: 31694272 DOI: 10.3390/biom9110698] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]